| Application no. and date | 09731612.9 (espacenet) (Federated) (European Patent Register), 20090414 | | Patent/reg. no. and date | DK/EP 2268648, 20120516 | | Publication date | 20110105 | | Priority no. and date | EP 08154517, 20080415 | | EP pub. no. and date |
EP 2268648 20110105 | | Effective date | | | Applicant/owner | Basilea Pharmaceutica International AG, Allschwil, Hegenheimermattweg 167b
4123 Allschwil, CH | | Applicant ref. no. | P49880DK01 | | Inventor | HEUBES, Markus, Drosselweg 3
79650 Schopfheim, DE,
CABRI, Walter, Via Pisacane 5
I-20089 Rozzano, IT,
ALPEGIANI, Marco, Via Tolmezzo 12/5
I-20132 Milano, IT,
LONGONI, Davide, Via Di Vittorio 11
I-20064 Gorgonzola, IT,
SCHLEIMER, Michael, Steinenweg 17
79594 Inzlingen, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/546 (2006.01) , A61P 31/00 (2006.01) , C07D 501/12 (2006.01) , C07D 501/54 (2006.01) | | Title | Krystallinsk (6R,7R)-7-{2-(5-amino-[1,2,4]thiadiazol-3-yl)-2-[(Z)-trityloxyimino]-acetylamino}-3-[(R)-1´-tert-butoxycarbonyl-2-oxo-[1,3]bipyrrolidinyl-(3E)-ylidenmethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-en-2-carboxylsyre-benzhydrylester, dets .... | | Int. application no. | EP2009054405 | | Int. publication no. | WO2009127623 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
